ATE499443T1 - In-vivo affinitätsreifungsschema - Google Patents

In-vivo affinitätsreifungsschema

Info

Publication number
ATE499443T1
ATE499443T1 AT03779576T AT03779576T ATE499443T1 AT E499443 T1 ATE499443 T1 AT E499443T1 AT 03779576 T AT03779576 T AT 03779576T AT 03779576 T AT03779576 T AT 03779576T AT E499443 T1 ATE499443 T1 AT E499443T1
Authority
AT
Austria
Prior art keywords
high frequency
polynucleotide sequence
affinity maturation
present
vivo
Prior art date
Application number
AT03779576T
Other languages
English (en)
Inventor
Robert Irving
Peter Hudson
Huseyin Mustafa
Kim Wark
Matias Abregu
Original Assignee
Quintain Consulting Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quintain Consulting Pty Ltd filed Critical Quintain Consulting Pty Ltd
Application granted granted Critical
Publication of ATE499443T1 publication Critical patent/ATE499443T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/02Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT03779576T 2002-12-18 2003-12-18 In-vivo affinitätsreifungsschema ATE499443T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002953381A AU2002953381A0 (en) 2002-12-18 2002-12-18 In vivo affinity maturation scheme
PCT/AU2003/001697 WO2004055182A1 (en) 2002-12-18 2003-12-18 In vivo affinity maturation scheme

Publications (1)

Publication Number Publication Date
ATE499443T1 true ATE499443T1 (de) 2011-03-15

Family

ID=30004466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03779576T ATE499443T1 (de) 2002-12-18 2003-12-18 In-vivo affinitätsreifungsschema

Country Status (8)

Country Link
US (1) US20060099611A1 (de)
EP (1) EP1576154B8 (de)
JP (1) JP2006510358A (de)
AT (1) ATE499443T1 (de)
AU (1) AU2002953381A0 (de)
CA (1) CA2510184C (de)
DE (1) DE60336170D1 (de)
WO (1) WO2004055182A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1395669B1 (de) 2001-01-26 2009-07-22 Selexis S.A. Matrix-anheftungsregionen und verfahren zu deren verwendung
PL1959011T3 (pl) 2003-10-24 2012-07-31 Selexis Sa Wysokowydajny transfer genu i ekspresja w komórkach ssaczych przez procedurę wielokrotnej transfekcji sekwencji regionu przylegania do macierzy
NZ579010A (en) 2007-02-20 2012-03-30 Anaptysbio Inc Somatic hypermutation systems
CN103687873B (zh) * 2011-07-12 2016-10-19 埃克斯生物科技公司 鉴定亲和力成熟的人类抗体
EP3802841A1 (de) * 2018-05-30 2021-04-14 Institute for Research in Biomedicine Manipulation von b-lymphozyten unter verwendung endogener aktivierbarer cytidindesaminase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909218D0 (en) * 1989-04-22 1989-06-07 Medical Res Council Improvements in or relating to enhancers
US5885827A (en) * 1996-01-23 1999-03-23 The Regents Of The Universtiy Of California Eukaryotic high rate mutagenesis system
US6232112B1 (en) * 1997-11-24 2001-05-15 Flinders Technologies Pty Ltd Of Flinders University Reagents and methods for diversification of DNA
JP4302894B2 (ja) * 1998-10-09 2009-07-29 メディカル リサーチ カウンシル 多様性を生み出す方法
US20020155453A1 (en) * 1998-10-09 2002-10-24 Sale Julian Edward Method for generating diversity
US20040156832A1 (en) * 2002-09-30 2004-08-12 Centec Limited Immunoglobulin compositions and methods

Also Published As

Publication number Publication date
EP1576154B1 (de) 2011-02-23
EP1576154B8 (de) 2011-04-13
EP1576154A4 (de) 2006-01-11
US20060099611A1 (en) 2006-05-11
CA2510184A1 (en) 2004-07-01
AU2002953381A0 (en) 2003-01-09
CA2510184C (en) 2013-09-17
JP2006510358A (ja) 2006-03-30
DE60336170D1 (de) 2011-04-07
WO2004055182A1 (en) 2004-07-01
EP1576154A1 (de) 2005-09-21

Similar Documents

Publication Publication Date Title
MXPA02003017A (es) Metodos y microorganismos para la produccion de panto-compuestos.
EP2336330A3 (de) An der Entwicklung von Pflanzenfasern beteiligte Polynukleotide und Polypeptide sowie Verfahren zur Verwendung davon
WO2002070729A3 (en) Improved skin substitutes and uses thereof
DE60030988D1 (de) Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
EP1474507A4 (de) Verfahren und materialien zur herstellung organischer produkte in zellen von candida-spezies
MX2008000200A (es) Polinucleotidos que codifican enzimas que modifican el isoprenoide y sus metodos de uso.
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
DE60142226D1 (de) Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden
GB2428044A (en) Method of forming mesenchymal stem cells from embryonic stem cells
DE60216581D1 (de) Verfahren und mikroorganismus zur verbesserten produktion von pantothenat
EA200700660A1 (ru) Мясные продукты и способ их получения
WO2004013312A3 (en) Tocopherol biosynthesis related genes and uses thereof
DE10345772A1 (de) Verfahren zur Herstellung von 3-Methylamino-1-(thien-2-yl)-propan-1-ol
DK1165759T3 (da) Polypeptider, der har forgrenende enzymaktivitet, og nukleinsyrer, der koder for samme
NO20062695L (no) Genvarianter kodende for proteiner fra metabolsk reaksjonsveien til finkjemikalier
EP1483384A4 (de) Verfahren zur überexpression zwitterionischer polysaccharide
BR0309766A (pt) Promotores usp semente especìficos para expressar genes em vegetais
DE60336170D1 (de) In-vivo affinitätsreifungsschema
WO2003064622A3 (en) Aggrecanase molecules
TW200502388A (en) Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
ATE530639T1 (de) Mikroorganismen und verfahren zur verbesserten produktion von panthothenat
AU2003236580A1 (en) Method of producing plants having enhanced transpiration efficiency and plants produced therefrom
ZA945639B (en) Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitillis
UA84172C2 (en) N-substituted pyrazolyl carboxanilides
PL2207795T3 (pl) Sposób wytwarzania dojrzałego, rekombinowanego alergenu grupy I roztoczy

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties